The ROE as of November 2024 (TTM) for IGM Biosciences, Inc. (IGMS) is -155.42%

According to IGM Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -155.42%. This represents a change of 249.82% compared to the average of -44.43% of the last 4 quarters.

IGM Biosciences, Inc. (IGMS) Historical ROE (quarterly & annually)

How has IGMS ROE performed in the past?

The mean historical ROE of IGM Biosciences, Inc. over the last ten years is 15.07%. The current -155.42% ROE has changed -1131.04% with respect to the historical average. Over the past ten years (40 quarters), IGMS's ROE was at its highest in in the March 2019 quarter at 152.11%. The ROE was at its lowest in in the March 2018 quarter at -1275.18%.

IGM Biosciences, Inc. (IGMS) ROE by Quarter and Year

Discovering the peaks and valleys of IGM Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IGM Biosciences, Inc. (IGMS) Average ROE

How has IGMS ROE performed in the past?

The current ROE of IGM Biosciences, Inc. (IGMS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IGM Biosciences, Inc. (IGMS) ROE vs. Peers

How is IGMS’s ROE compared to its peers?

IGM Biosciences, Inc.’s ROE is greater than Avidity Biosciences, Inc. (-27.66%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Design Therapeutics, Inc. (-18.01%), greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Ikena Oncology, Inc. (-39.59%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Gracell Biotechnologies Inc. (-15.56%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than Erasca, Inc. (-42.26%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Revolution Medicines, Inc. (-33.67%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Atreca, Inc. (-199.88%), greater than Passage Bio, Inc. (-72.53%),

Build a custom stock screener for IGM Biosciences, Inc. (IGMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGM Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IGM Biosciences, Inc. (IGMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IGM Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.